HER2CLIMB-05 Trial at SABCS 2025: Tucatinib Plus HP as First-Line Maintenance in HER2-Positive Metastatic Breast Cancer

HER2CLIMB-05

A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma

A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma

Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening

St. Jude Children’s Research Hospital

Douglas Flora: The End of Cut, Poison and Burn - How AI is Rewriting Cancer Care

Douglas Flora

Stephanie Weiner: U.S. Medical School Enrollment Surpasses 100,000 for the First Time

Stephanie Weiner

Oncology News, Insights, Stories by OncoDaily

European Cancer Forum
Voices

European Cancer Forum 2025: Innovation, Security and Sustainability

Bristol Myers Squibb
Voices

Bristol Myers Squibb’s Opdivo-Plus-Chemotherapy Regimen for Classical Hodgkin Lymphoma Receives FDA Priority Review

10 most promising cancer drugs 2025
Oncolibrary

10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily

A Man From the Roman Empire Diagnosed With Metastatic Cancer 1,700 Years After His Death

Inside SABCS 2025 with Paolo Tarantino

SIOP is Calling for Nominations for its 2026 Board of Directors

Synthetic Lethality in Oncology: Challenges, Trials & Future Therapies (2025 Update)

SABCS 2025: A New Framework for Endocrine Therapy in HR+/HER2– Metastatic Breast Cancer

20 Posts Not to Miss from SABCS 2025, Part 2

PFS as a Surrogate for OS in First-Line Immunotherapy: Results from 18 Trials Meta-Analysis in GEA and ESCC

awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Voices
Andres Felipe Cardona Zorrilla

Andrés Felipe Cardona Zorrilla: Great Pride for the Institutional Achievement in the National Medicine Award

Sarju Ganatra: New CardioOncology American College of Cardiology Concise Clinical Guidance

Jame Abraham: Trastuzumab Deruxtecan in Residual HER2+ Early Breast Cancer

Olubukola Ayodele: It's the Treatment that Fails the Patient, Not the Patient Who Fails the Treatment

His Presence Was Felt When He Walked into Any Room... - IASLC

The Power of Coming Together Over Christmas - World Child Cancer

Kefah Mokbel: Surgery-Free Tamoxifen for Low-Risk DCIS

Celebrities and Cancer

OncoCalendar

Colorectal Liver Metastasis Consensus Conference

MD Anderson Cancer Center

24 Feb
Colorectal Liver Metastasis

2026 International Cancer Neuroscience Symposium

MD Anderson Cancer Center

18 Feb
International Cancer Neuroscience Symposium

The 25th International Cancer Imaging Society Meeting and Annual Teaching Course

International Cancer Imaging Society (ICIS)

23 Sep
Cancer Imaging Society

Joint Meeting of ICIS and ORMIS: From Oman to the World: Defining New Horizons in Medical Imaging

International Cancer Imaging Society (ICIS)

30 Jan
ICIS

ICISi Masterclass in Current Topics of Renal and Adrenal Imaging

International Cancer Imaging Society (ICIS)

11 Feb
ICISi Masterclass

Immune-oncology
Immuno-Oncology

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The "Off-the-Shelf" Revolution: How iNKT Cell Therapy agenT-797 is Reprogramming the Fight Against Solid Tumors

10 Posts Not to Miss from ESMO

GDFather-NEO Trial at ESMO 2025: Visugromab Plus Nivolumab Triples Response in Neoadjuvant MIBC

IMMUNOSARC II at ESMO 2025: Nivolumab + Sunitinib in Advanced Alveolar Soft-Part Sarcoma

AEGEAN: Radiomics and on-treatment ctDNA predict pCR and associate with EFS in resectable NSCLC

OncoGrants
American Brain Tumor Association Basic Research Fellowships

American Brain Tumor Association Basic Research Fellowships

American Brain Tumor Association Medical Student Summer Fellowships

American Brain Tumor Association Medical Student Summer Fellowships

AACR-EMD Serono “I’M IN” Oncodisparity Fellowship for Bladder Cancer

AACR-EMD Serono “I’M IN” Oncodisparity Fellowship for Bladder Cancer

American Cancer Society Catalyst Award

American Cancer Society Catalyst Award

Leukemia Research Foundation New Investigator Grant Program

Leukemia Research Foundation New Investigator Grant Program

Lustgarten

Lustgarten Foundation Innovation & Collaboration Program

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Dragana Stanić Tišma

Dragana Stanić Tišma

Belgrade, Serbia
Robert E. Reiter

Robert E. Reiter

Los Angeles, USA
Alexandra Müller

Alexandra Müller

Freiburg, Germany
Etienne Brain

Etienne Brain

Saint-Cloud, France
Enrique Soto Perez de Celis

Enrique Soto Pérez de Celis

Aurora, USA
Gabriele Todisco

Gabriele Todisco

Milan, Italy
Francesco Massari

Francesco Massari

Bologna, Italy
Elie Dib

Elie G. Dib

Baltimore, USA

Oncology Drugs
amivantamab

Amivantamab for Lung Cancer: What Patients Need to Know

Amivantamab: A Deep Dive Into Its Mechanism, Clinical Data, and Expanding Role in EGFR-Driven Non–Small Cell Lung Cancer

Relacorilant: A New Treatment Approach for Women With Platinum-Resistant Ovarian Cancer

Relacorilant: A Selective Glucocorticoid Receptor Modulator Reshaping Treatment in Platinum-Resistant Ovarian Cancer

Zanzalintinib: What Patients Need to Know About This New Treatment for Colorectal Cancer

Zanzalintinib in MSS Metastatic Colorectal Cancer

Sacituzumab Govitecan (Trodelvy): What Patients Need to Know in 2025?

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
CHRYSALIS-2 Trial

Treatment Outcomes With Amivantamab–Lazertinib in EGFR Mutant NSCLC: CHRYSALIS-2 Trial

GCD vx GCS

New GI Paper Alert: Durvalumab plus gemcitabine-cisplatin versus S-1 plus gemcitabine-cisplatin in advanced biliary tract cancer.

INTERACT-ION Trial

INTERACT-ION Trial: Ezabenlimab Plus mDCF Induction Improves Complete Response Rates in Anal Cancer

CCL7 Macrophages

CCL7-Positive Tumor-Associated Macrophages Drive Immune Checkpoint Resistance in Colorectal Cancer

TRYBECA-1 Trial

TRYBECA-1 Trial: Eryaspase Added to Second-Line Chemotherapy in Advanced PDAC

Sevabertinib

Sevabertinib Shows High Response Rates in HER2-Mutant Non–Small-Cell Lung Cancer: Results from the SOHO-01 Trial

OncoDaily Medical Journal

Precision Oncology

10.69690/ODMJ-019-0829-4588

Harnessing Real-World Evidence to Support Precision Oncology
Opinion

Pediatric Oncology

10.69690/ODMJ-001-0829-4568

Identifying the Factors Contributing to Treatment Abandonment in Childhood Cancers at a Tertiary Care Hospital in Pakistan
Original Research

Global Oncology

10.69690/ODMJ-001-0811-4701

The Role of National and Regional Cancer Registries in Shaping Cancer Care Policies
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0809-4599

Survival Outcomes of Wilms' Tumor in Pediatric Patients Treated at KFMC: A Retrospective Study of 15 years from 2007-2022
Original Research

GI Oncology

10.69690/ODMJ-018-0425-4320

Colorectal Cancer in Latin America: Quick Comment
Commentaries

GI Oncology

10.69690/ODMJ-002-0701-4309

Current Perspective of Gastro-intestinal Cancer in Guatemala
Review/Meta-Analysis

Pediatric Oncology

10.69690/ODMJ-003-0520-4233

In the Crossfire: A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group
Editorial

Pediatric Oncology

10.69690/ODMJ-018-0425-4062

CD19+ CAR-T Therapy for Relapsed or Refractory B-ALL and Burkitt Lymphoma in Children and Young Adults in the Republic of Belarus
Abstracts